Application of risk factors for venous thromboembolism in patients with multiple myeloma starting chemotherapy, a real-world evaluation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Application of risk factors for venous thromboembolism in patients with multiple myeloma starting chemotherapy, a real-world evaluation

Published:2018-12-25 Issue:1 Volume:8 Page:455-462
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Baker Hailey A.¹^ORCID,Brown Alexandra R.²,Mahnken Jonathan D.²,Shireman Theresa I.³,Webb Carol E.⁴,Lipe Brea C.⁵^ORCID

Affiliation:

1. University of Kansas School of Medicine; Wichita Kansas

2. University of Kansas Medical Center; Kansas City Kansas

3. Brown University School of Public Health; Providence Rhode Island

4. University of Kansas Cancer Center; Kansas City Kansas

5. University of Rochester Medical Center; Rochester New York

Funder

American Cancer Society

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cam4.1927/fullpdf

Reference32 articles.

1. Venous thromboembolism in the hematologic malignancies;Falanga;Curr Opin Oncol,2012

2. Cancer Facts & Figures 2016 Atlanta American Cancer Society 2016

3. Incidence of venous thrombosis in a large cohort of 66,329 cancer patients: results of a record linkage study;Blom;J Thromb Haemost,2006

4. Arterial and venous thrombosis in monoclonal gammopathy of undetermined significance and multiple myeloma: a population-based study;Kristinsson;Blood,2010

5. Immunomodulator drug-based therapy in myeloma and the occurrence of thrombosis;Boyle;Expert Rev Hematol,2012

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiple Myeloma Drug Therapy: Considerations on Effectiveness and Safety;Interdisciplinary Cancer Research;2024

2. Incidence of thromboembolism and associated factors in multiple myeloma patients treated with immunomodulatory drugs: a retrospective analysis in Belo Horizonte, Brazil;Supportive Care in Cancer;2023-12-16

3. Development and validation of a new risk assessment model for immunomodulatory drug-associated venous thrombosis among Chinese patients with multiple myeloma;Thrombosis Journal;2023-10-04

4. Understanding risks and refining strategies for thromboembolism prophylaxis in hematopoietic stem cell transplant recipients;Bone Marrow Transplantation;2023-08-25

5. Stratification of Venous Thromboembolism Risk in Multiple Myeloma and Analysis of the Use of Antithrombotic Agents;Journal of Korean Society of Health-System Pharmacists;2023-05-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3